Intercambiar VitaFOXO VITAFOXO a MegaETH MEGA

This project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease. They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.

MegaETH is the first real-time blockchain, delivering streaming throughput with 10-millisecond latency and up to 100,000 TPS. Developers scale applications with real-time state streaming, while users experience instant transactions. On top of this foundation, MegaETH onboards a new class of applications through its accelerator program, MegaMafia. These applications range from RWA and FX to entertainment finance and complex, fully onchain DEXs. $MEGA is the network token of MegaETH and serves as the economic engine of the ecosystem. Its design rests on two pillars: $USDm, which drives value accrual as capital is deployed across a growing set of native applications, and proximity markets, which monetize access to real-time execution.